Lorence H. Kim is Chief Financial Officer of Moderna, Inc.. Currently has a direct ownership of 1.2 Million shares of MRNA, which is worth approximately $44.3 Million. The most recent transaction as insider was on Jun 02, 2020, when has been sold 241,000 shares (Common Stock) at a price of $58.3 per share, resulting in proceeds of $14,050,300. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.2M
0% 3M change
0% 12M change
Total Value Held $44.3 Million

Lorence H. Kim Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 02 2020
SELL
Open market or private sale
$14,050,300 $58.3 p/Share
241,000 Reduced 16.7%
1,202,510 Common Stock
Jun 02 2020
BUY
Exercise of conversion of derivative security
$4,219,910 $17.51 p/Share
241,000 Added 14.31%
1,443,510 Common Stock
May 27 2020
SELL
Open market or private sale
$12,322,330 $51.13 p/Share
241,000 Reduced 16.7%
1,202,510 Common Stock
May 27 2020
BUY
Exercise of conversion of derivative security
$3,186,020 $13.22 p/Share
241,000 Added 14.31%
1,443,510 Common Stock
May 18 2020
SELL
Open market or private sale
$19,795,740 $82.14 p/Share
241,000 Reduced 16.7%
1,202,510 Common Stock
May 18 2020
BUY
Exercise of conversion of derivative security
$3,186,020 $13.22 p/Share
241,000 Added 14.31%
1,443,510 Common Stock
May 15 2020
SELL
Open market or private sale
$1,307,400 $65.37 p/Share
20,000 Reduced 1.64%
1,202,510 Common Stock
May 12 2020
SELL
Open market or private sale
$15,665,000 $65.0 p/Share
241,000 Reduced 16.47%
1,222,510 Common Stock
May 12 2020
BUY
Exercise of conversion of derivative security
$2,785,960 $11.56 p/Share
241,000 Added 14.14%
1,463,510 Common Stock
Apr 15 2020
SELL
Open market or private sale
$730,000 $36.5 p/Share
20,000 Reduced 1.61%
1,222,510 Common Stock
Mar 16 2020
SELL
Open market or private sale
$523,400 $26.17 p/Share
20,000 Reduced 1.58%
1,242,510 Common Stock
Mar 04 2020
SELL
Open market or private sale
$554,200 $27.71 p/Share
20,000 Reduced 1.56%
1,262,510 Common Stock
Feb 26 2020
SELL
Open market or private sale
$536,058 $28.74 p/Share
18,652 Reduced 1.43%
1,282,510 Common Stock
Feb 25 2020
SELL
Open market or private sale
$34,873 $25.87 p/Share
1,348 Reduced 0.1%
1,301,162 Common Stock
Feb 07 2020
SELL
Open market or private sale
$767,783 $23.06 p/Share
33,295 Reduced 2.49%
1,302,510 Common Stock
Jan 28 2020
SELL
Open market or private sale
$21,033 $23.37 p/Share
900 Reduced 0.07%
1,335,805 Common Stock
Jan 27 2020
SELL
Open market or private sale
$547,753 $23.01 p/Share
23,805 Reduced 1.75%
1,336,705 Common Stock
Jan 22 2020
SELL
Open market or private sale
$46,080 $23.04 p/Share
2,000 Reduced 0.15%
1,360,510 Common Stock
Dec 06 2019
SELL
Open market or private sale
$4,823,117 $20.22 p/Share
238,532 Reduced 14.9%
1,362,510 Common Stock
Dec 06 2019
BUY
Exercise of conversion of derivative security
$9,467,877 $20.64 p/Share
458,715 Added 22.27%
1,601,042 Common Stock
Sep 23 2019
SELL
Bona fide gift
-
5,000 Reduced 0.44%
1,142,327 Common Stock
Dec 11 2018
BUY
Conversion of derivative security
-
458 Added 0.04%
1,147,327 Common Stock

Also insider at

COWN
COWEN INC. Financial Services
RVMD
Revolution Medicines, Inc. Healthcare
ABC
AMERISOURCEBERGEN CORP Healthcare
LHK

Lorence H. Kim

Chief Financial Officer
Cambridge, MA

Track Institutional and Insider Activities on MRNA

Follow Moderna, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRNA shares.

Notify only if

Insider Trading

Get notified when an Moderna, Inc. insider buys or sells MRNA shares.

Notify only if

News

Receive news related to Moderna, Inc.

Track Activities on MRNA